Document is current
Any future updates will be listed below
-
Authors
Kuroda, Ryosuke
Niikura, Takahiro http://orcid.org/0000-0003-0951-5812
Matsumoto, Tomoyuki
Fukui, Tomoaki
Oe, Keisuke
Mifune, Yutaka
Minami, Hironobu
Matsuoka, Hiroshi
Yakushijin, Kimikazu
Miyata, Yoshiharu
Kawamoto, Shinichiro
Kagimura, Tatsuo
Fujita, Yasuyuki
Kawamoto, Atsuhiko
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21bk0104108)
- License Information
-
More Information
Article History
Received: 18 June 2023
Accepted: 21 September 2023
First Online: 5 October 2023
Declarations
:
: The study protocol conformed to the Declaration of Helsinki and was approved by the institutional review boards of Kobe University Hospital, Teikyo University Hospital, Iwate Medical University Hospital, Kagawa University Hospital, Hyogo Medical University Hospital, Kobe City Medical Center General Hospital, and Institute of Biomedical Research and Innovation Hospital. A clinical trial notification was submitted to the Pharmaceuticals and Medical Devices Agency (PMDA), Japan, and the study was initiated after obtaining the PMDA’s permission. Furthermore, ethical approval was obtained from all seven participating hospitals. All patients provided written informed consent to participate in this trial. This trial has been registered at UMIN-CTR under UMIN000022814. There are no restrictions on study-related materials.
: Not applicable.
: The authors declare that they have no competing interests.
